Metabolon Appoints Michael Irwin as Vice President and Global Head of Sales

Metabolon Welcomes Michael Irwin as New VP of Global Sales

In a significant move that marks a pivotal moment in its growth, Metabolon, Inc.—a global leader in metabolomic solutions—has announced the appointment of Michael Irwin as the Vice President and Global Head of Sales. Irwin joins the company with a wealth of experience, including his previous role as Global Sales Director at Olink, where he honed his expertise in the rapidly evolving life sciences sector.

Embracing the Omics Revolution

As the life sciences industry increasingly embraces a holistic omics approach to research, Michael Irwin's extensive background in both proteomics and genomics comes at a critical juncture for Metabolon. In his new role, he will drive the company's global sales strategy as it seeks to strengthen its competitive position in the emerging multiómics market.

Dr. Rohan Hastie, Metabolon’s President and Chief Executive Officer, expressed his enthusiasm about Irwin's arrival, stating, "We are thrilled to welcome Michael to the Metabolon leadership team at such a crucial time for our company. His expertise will be invaluable in positioning Metabolon as a leader in the multiómics space."

Driving Growth Through Expertise

Michael Irwin is no stranger to high stakes sales environments; he boasts over three decades of experience and a history of driving revenue growth in challenging markets. His strategic insight and proven track record of developing successful business strategies will play a key role as Metabolon aims to expand its offerings and penetrate new markets.

In his own words, Irwin stated, "Metabolon’s Global Discovery Panel leads the industry in providing rigorous analysis of biological systems to identify biomarkers and assess drug effects. With the upcoming launch of our integrated bioinformatics platform and data analytics tools, our services will be unparalleled in the industry. I am excited to lead Metabolon’s next growth phase!"

Innovative Solutions and Future Directions

Metabolon’s Global Discovery Panel, renowned for its comprehensive metabolomic analysis, utilizes the largest proprietary metabolomics reference library in the world. This initiative, coupled with Metabolon’s free bioinformatics tools, is designed to address some of the most pressing and challenging questions within biological sciences.

The firm’s extensive experience in translational science and pharmacometabolomics enables partners to bridge critical gaps in research—from initial discovery through to clinical trials and product lifecycle management.

As the company continues to innovate in metabolomics and lipidomics, it aims to provide scalable and customizable solutions to meet the diverse demands of its clients.

For more on Metabolon’s services, visit their Global Discovery Panel or check out the Integrated Bioinformatics Platform.

About Metabolon

Metabolon, Inc. stands at the forefront of metabolomics, dedicated to delivering biochemical data and insights to enhance and accelerate the impact of research in biological sciences. With over 20 years in operation and over 10,000 projects under its belt, Metabolon has accumulated an impressive portfolio that includes more than 3,000 publications and certifications in ISO 9001:2015, CLIA, and CAP.

The company’s commitment to excellence and leadership in the field is reflected in its ongoing quest to address complex biological questions, helping clients navigate the intricacies of metabolomics in health research and therapeutic development. Find out more about their groundbreaking solutions at Metabolon and follow them on LinkedIn and Twitter for the latest updates.